International Medical Ventures Announces Signed Agreement With Clinigene International Ltd

BASEL CITY, Switzerland - Jan. 6, 2014 - PRLog -- International Medical Ventures is pleased to announce it has signed an agreement with Clinigene International Ltd of Bangalore India. The basic agreement serves to explore the potential advancement of International Medical Ventures' objective for the development of an In-Home BRCA 1 and BRCA 2 genetic marker test kit. The predictive diagnostics market has been forecast to reach a total of $810.5 million by the end of 2018, driven by a number of key factors, including next generation genetic sequencing, aging population, and increasing incidence and prevalence of chronic degenerative diseases.

Mrs. Helge Amacker, Director of International Business Development said, "Clinigene International has established itself as a world leader in CRO and trials management. Our hope is that together, our objective to bring to market an affordable predictive diagnostic test kit is achieved."

Mrs. Amacker added, "Clinigene International's successful record and India's broad population, faster recruitment and low-cost environment, provides the ideal landscape to improve R&D capabilities as well as develop previously uneconomical 'niche busters' and emerging technologies including predictive diagnostics."

About Clinigene International Limited
Clinigene International Limited is a full-service Clinical Research Organization providing world-class clinical research solutions to global pharmaceutical and biotechnology companies. Clinigene is a subsidiary of India's largest biotech company Biocon global biopharma enterprise, serving its partners and customers in over 75 countries.

About International Medical Ventures, Inc.
International Medical Ventures is a Swiss based venture capital firm which leads or manages private equity and venture investments in biotechnology, life science, medical device companies and healthcare services in all stages of developments. The company has established relationships with some of the industry's leading institutions to offer emerging companies and investors opportunities in unique new businesses.

Press Office
Contact Person:  Mr. Lars Sollberger
Position:          Press Officer
Email:          press@imedvt dot com

Business Development
Contact Person:  Mrs. Helge Amacker
Position:          Director of International Business Development
Email:          helge@imedvt dot com

Telephone: +41 (61) 508-7009

Mr. Lars Sollberger
+41 (61) 508-7009
Source:International Medical Ventures/Clinigene Internat
Email:*** Email Verified
Tags:Biotech, Life Science, Venture Capital, Healthcare, Finance, Private Equity
Industry:Biotech, Finance, Health
Location:Basel City - Basel - Switzerland
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jan 07, 2014

Like PRLog?
Click to Share